Publications

5674 Results

Quantitative protein and gene expression biomarkers of tamoxifen and letrozole recurrence in the NCIC CTG MA.17 cohort

Authors
DC Sgroi;DM Finkelstein;L Shepherd;JN Ingle;DL Rimm;H Sassano;P Porter;M Pins;S Paik;A Ristimaki;K Pritchard;D Tu;PE Goss
Journal / Conference
San Antoino Breast Cancer Symposium, abst. #p3-10-26; poster
Year
2010
Research Committee(s)
Breast
Study Number(s)
JMA17

Final analysis of NCIC CTG MA.27: a randomized phase III trial of exemestane versus anastrozole in post-menopausal women with hormone receptor positive primary breast cancer

Authors
PE Goss;JN Ingle;MJ Ellis;G Sledge;GT Budd;M Ragaglio;K Gelmon;L Shepherd;KI Pritchard
Journal / Conference
San Antonio Breast Cancer Symposium, #S1-1; poster
Year
2010
Research Committee(s)
Breast

Patient selection for cetuximab in NSCLC: A systematic review of candidate predictive biomarkers

Authors
J Harbison;D Horak;S Maier;TJ Lynch;D Gandara;KJ O'Byrne;R Pirker;M Weber;S Khambata-Ford
Journal / Conference
Journal of Clinical Oncology 28:15s (suppl; abstr 7548); ASCO annual meeting; poster
Year
2010
Research Committee(s)
Lung
Study Number(s)
S0342, S0536

KRAS and EGFR mutations in the molecular epidemiology of NSCLC: Interim analysis of S0424

Authors
PC Mack;M Redman;K Chansky;S Matsumoto;W Holland;P Lara;C Ambrosone;DR Gandara
Journal / Conference
Journal of Clinical Oncology 28:15s, 2010 (suppl; abstr 7013); ASCO annual meeting; poster
Year
2010
Research Committee(s)
Lung
Study Number(s)
S0424

A phase III randomized, double-blind, placebo-controlled trial of the epidermal growth factor receptor inhibitor gefitinb in completely resected stage IB-IIIA non-small cell lung cancer (NSCLC): NCIC CTG BR.19

Authors
GD Goss;I Lorimer;MS Tsao;CJ O'Callaghan;K Ding;GA Masters;D Gandara;JR Jett;MJ Edelman;FA Shepherd
Journal / Conference
Journal of Clinical Oncology 28:18s, 2010 (suppl; abstr LBA7005); ASCO annual meeting; poster
Year
2010
Research Committee(s)
Lung

A phase III, intergroup, randomized, double-blind, chemoprevention trial of selenium (Se) supplementation in resected stage I non-small cell lung cancer (NSCLC)

Authors
D Karp;J Lee;L Shaw Wright;DH Johnson;MR Johnston;GE Goodman;GH Clamon;GS Okawara;R Marks;J Ruckdeschel
Journal / Conference
Journal of Clinical Oncology 28:18s, 2010 (suppl; abstr CRA7004); ASCO Annual Meeting; oral
Year
2010
Research Committee(s)
Lung
Study Number(s)
E5597

Fulvestrant with or without Lapatinib as Therapy for Hormone Receptor Positive Advanced Breast Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Study

Authors
HJ Bernstein;WT Barry;C Cirrincione;HK Chew;S Tolaney;D Lake;T Pluard;K Blackwell;E Winer;CA Hudis
Journal / Conference
Cancer Research 2010; 70(24 suppl 2 ): abstr PD05-01; SABCS annual meeting; poster discussion
Year
2010
Research Committee(s)
Breast

N0733: Phase II trial of capecitabine and lapatinib plus or minus cixutumumab in HER2-positive breast cancer

Authors
P Haluska;M Reinholz;AC Dueck;H Linden;W Lingle;AM Bernath;M Arbushites;H Youssoufian;HX Chen;EA Perez
Journal / Conference
Journal of Clinical Oncology 28:15s:(suppl; abstr TPS129); Trials in Progress poster presentation
Year
2010
Research Committee(s)
Breast

Impact of high-dose chemotherapy on the ability to deliver subsequent local-regional radiotherapy for breast cancer: analysis of Cancer and Leukemia Group B Protocol 9082

Authors
LB Marks;C Cirrincione;TJ Fitzgerald;F Laurie;AS Glicksman;J Vredenburgh;LR Prosnitz;EJ Shpall;M Crump;PG Richardson;MW Schuster;J Ma;BL Peterson;L Norton;S Seagren;IC Henderson;DD Hurd;WP Peters
Journal / Conference
Int. J. Radiat. Oncol. Biol. Phys. 76(5):1305-1313
Year
2010
Research Committee(s)
Breast
PMID
PMID19747781
PMC
PMC3670136
Study Number(s)
SWOG-9114 (INT-0163) (CALGB-9082)

Cyclophosphamide, epirubicin, and fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by paclitaxel versus doxorubicin and cyclophosphamide followed by paclitaxel in node-positive or high-risk node-negative breast cancer

Authors
M Burnell;MN Levine;JW Chapman;V Bramwell;K Gelmon;B Walley;T Vandenberg;H Chalchal;K Albain;EA Perez;R Rugo;K Pritchard;P O'Brien;LE Shepherd
Journal / Conference
Journal of Clinical Oncology 28(1):77-82
Year
2010
Research Committee(s)
Breast
PMID
PMID19901117
PMC
PMC2799234